185 related articles for article (PubMed ID: 36189292)
1. Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.
Azam K; Khosa C; Viegas S; Massango I; Bhatt N; Jani I; Heinrich N; Hoelscher M; Gillespie SH; Rachow A; Sabiiti W
Front Immunol; 2022; 13():1005692. PubMed ID: 36189292
[TBL] [Abstract][Full Text] [Related]
2. High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis.
Musisi E; Sessolo A; Kaswabuli S; Zawedde J; Byanyima P; Kasinga S; Sanyu I; Uwimaana E; Walimbwa S; Olore J; Ssengooba W; Sekaggya C; Joloba ML; Worodria W; Huang L; Gillespie SH; Sloan DJ; Sabiiti W
Microbiol Spectr; 2022 Feb; 10(1):e0210021. PubMed ID: 35019686
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB/RIF Ultra, and culture in Uganda.
Musisi E; Wamutu S; Ssengooba W; Kasiinga S; Sessolo A; Sanyu I; Kaswabuli S; Zawedde J; Byanyima P; Kia P; Muwambi W; Toskin DT; Kigozi E; Walbaum N; Dombay E; Legrady MB; Ssemambo KD; Joloba M; Kuchaka D; Worodria W; Huang L; Gillespie SH; Sabiiti W
Lancet Microbe; 2024 Apr; 5(4):e345-e354. PubMed ID: 38458206
[TBL] [Abstract][Full Text] [Related]
4. Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections.
Mapamba DA; Sauli E; Lalashowi J; Buza J; John J; Mwaisango Z; Tarmo P; Sabi I; Rachow A; Ntinginya NE; Mtafya B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835127
[TBL] [Abstract][Full Text] [Related]
5. Molecular Bacterial Load Assay Concurs with Culture on NaOH-Induced Loss of Mycobacterium tuberculosis Viability.
Mtafya B; Sabiiti W; Sabi I; John J; Sichone E; Ntinginya NE; Gillespie SH
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018981
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
[TBL] [Abstract][Full Text] [Related]
7. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay.
Sabiiti W; Azam K; Farmer ECW; Kuchaka D; Mtafya B; Bowness R; Oravcova K; Honeyborne I; Evangelopoulos D; McHugh TD; Khosa C; Rachow A; Heinrich N; Kampira E; Davies G; Bhatt N; Ntinginya EN; Viegas S; Jani I; Kamdolozi M; Mdolo A; Khonga M; Boeree MJ; Phillips PPJ; Sloan D; Hoelscher M; Kibiki G; Gillespie SH
Thorax; 2020 Jul; 75(7):606-608. PubMed ID: 32354738
[TBL] [Abstract][Full Text] [Related]
9. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
[TBL] [Abstract][Full Text] [Related]
10. Systematic assessment of clinical and bacteriological markers for tuberculosis reveals discordance and inaccuracy of symptom-based diagnosis for treatment response monitoring.
Mtafya B; Sabi I; John J; Sichone E; Olomi W; Gillespie SH; Ntinginya NE; Sabiiti W
Front Med (Lausanne); 2022; 9():992451. PubMed ID: 36419786
[TBL] [Abstract][Full Text] [Related]
11. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.
Machowski EE; Letutu M; Lebina L; Waja Z; Msandiwa R; Milovanovic M; Gordhan BG; Otwombe K; Friedrich SO; Chaisson R; Diacon AH; Kana B; Martinson N
BMC Infect Dis; 2021 May; 21(1):466. PubMed ID: 34022850
[TBL] [Abstract][Full Text] [Related]
12. A practical approach to render tuberculosis samples safe for application of tuberculosis molecular bacterial load assay in clinical settings without a biosafety level 3 laboratory.
Mtafya B; Qwaray P; John J; Sichone E; Shoo A; Gillespie SH; Ntinginya NE; Sabiiti W
Tuberculosis (Edinb); 2023 Jan; 138():102275. PubMed ID: 36434867
[TBL] [Abstract][Full Text] [Related]
13. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.
Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Mugerwa RD; Ellner JJ; Eisenach KD
Int J Tuberc Lung Dis; 2000 Jun; 4(6):528-36. PubMed ID: 10864183
[TBL] [Abstract][Full Text] [Related]
14. Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis.
Brown J; Clark K; Smith C; Hopwood J; Lynard O; Toolan M; Creer D; Barker J; Breen R; Brown T; Cropley I; Lipman M
BMC Infect Dis; 2016 Jun; 16():265. PubMed ID: 27287260
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
[TBL] [Abstract][Full Text] [Related]
16. Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting.
Theron G; Peter J; Lenders L; van Zyl-Smit R; Meldau R; Govender U; Dheda K
PLoS One; 2012; 7(5):e37436. PubMed ID: 22629395
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Mycobacterium tuberculosis molecular bacterial load assay, microscopy and GeneXpert versus liquid culture for viable bacterial load quantification before and after starting pulmonary tuberculosis treatment.
Hai HT; Vinh DN; Thu DDA; Hanh NT; Phu NH; Srinivasan V; Thwaites GE; T T Thuong N
Tuberculosis (Edinb); 2019 Dec; 119():101864. PubMed ID: 31568973
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
19. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
[TBL] [Abstract][Full Text] [Related]
20. A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA).
Sabiiti W; Mtafya B; De Lima DA; Dombay E; Baron VO; Azam K; Oravcova K; Sloan DJ; Gillespie SH
J Vis Exp; 2020 Apr; (158):. PubMed ID: 32420999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
